Deqiang Niu

CEO at Artivila Biopharma

Presenter

B.S. from Peking University, M.S. from Peking University, Ph.D. from New York University, Postdoctoral Researcher from Columbia University. Dr. Niu previously served as Vice President at Silicon Therapeutics, Chemistry Director at Celgene, Pharmaceutical Chemist Expert and Chemistry Associate Director at Enanta Pharmaceuticals, Biogen and Avila Therapeutics. He has more than 20 years of drug development experience with more than 60 US patents and PCT patents. He led or participated in over 10 projects/compounds that advanced into clinical stages, which include the 3rd generation EGFR inhibitor,an HCV drug, and several clinical candidates in Celgene.